The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension
Yeon Seok Seo, Vijay H. Shah
Clin Mol Hepatol. 2012;18(4):337-346.   Published online 2012 Dec 21     DOI: https://doi.org/10.3350/cmh.2012.18.4.337
Citations to this article as recorded by Crossref logo
Effects of direct anti-viral agents on the gut microbiota in patients with chronic hepatitis C
Pao-Yuan Huang, Chien-Hung Chen, Mu-Jung Tsai, Chih-Chien Yao, Hsin-Ming Wang, Yuan-Hung Kuo, Kuo-Chin Chang, Chao-Hung Hung, Seng-Kee Chuah, Ming-Chao Tsai
Journal of the Formosan Medical Association.2022;[Epub]     CrossRef
Alterations in circadian rhythms aggravate Acetaminophen-induced liver injury in mice by influencing Acetaminophen metabolization and increasing intestinal permeability
Kun Zhang, Xiude Fan, Xiaoyun Wang, Xiaoge Zhang, Lu Zeng, Na Li, Qunying Han, Yi Lv, Zhengwen Liu
Bioengineered.2022; 13(5): 13118.     CrossRef
7-O-(2- (Propylamino)-2-oxoethyl) hesperetin attenuates inflammation and protects against alcoholic liver injury by NLRP12
Xue-ni Niu, Yi-long Zhang, Miao Cheng, Na-na Yin, Yuan-yuan Wu, Wen Shi, Ying-li Yang, Lin Zhu, Cheng Huang, Jun Li
International Immunopharmacology.2022; 110: 109006.     CrossRef
Konjac oligosaccharides attenuate DSS-induced ulcerative colitis in mice: mechanistic insights
Pengkui Xia, Tao Hou, Muyuan Ma, Sha Li, Hong Jin, Xuan Luo, Jing Li, Fang Geng, Bin Li
Food & Function.2022; 13(10): 5626.     CrossRef
Inchinkoto, the Traditional Japanese Kampo Medicine, Enhances Intestinal Epithelial Barrier Function In Vitro
Ayaka Nakao, Ailing Hu, Takuji Yamaguchi, Masahiro Tabuchi, Yasushi Ikarashi, Hiroyuki Kobayashi, Talha Bin Emran
Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1.     CrossRef
New perspective on fecal microbiota transplantation in liver diseases
Ki Tae Suk, Hong Koh
Journal of Gastroenterology and Hepatology.2022; 37(1): 24.     CrossRef
Influence of Gut–Liver Axis on Portal Hypertension in Advanced Chronic Liver Disease: The Gut Microbiome as a New Protagonist in Therapeutic Management
Francesco Santopaolo, Gaetano Coppola, Lucia Giuli, Antonio Gasbarrini, Francesca Romana Ponziani
Microbiology Research.2022; 13(3): 539.     CrossRef
Food-Specific IgE and IgG Antibodies in Patients With Chronic Rhinosinusitis With Nasal Polyps: A Case–Control Study
Rafaela Veloso-Teles, Rui Cerejeira, Débora Rodrigues, Rosa Roque-Farinha, Christian von Buchwald
Ear, Nose & Throat Journal.2021; 100(3): 177.     CrossRef
Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications
Csaba Matyas, György Haskó, Lucas Liaudet, Eszter Trojnar, Pal Pacher
Nature Reviews Cardiology.2021; 18(2): 117.     CrossRef
TNFR1 and the TNFα axis as a targetable mediator of liver injury from stereotactic body radiation therapy
Matthew M. Cousins, Emily Morris, Christopher Maurino, Theresa P. Devasia, David Karnak, Dipankar Ray, Neehar D. Parikh, Dawn Owen, Randall K. Ten Haken, Matthew J. Schipper, Theodore S. Lawrence, Kyle C. Cuneo
Translational Oncology.2021; 14(1): 100950.     CrossRef
The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy
Zefeng Chen, Jingsheng Ruan, Dinghua Li, Min Wang, Zhiwei Han, Wenxia Qiu, Guobin Wu
Frontiers in Cellular and Infection Microbiology.2021;[Epub]     CrossRef
The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies
Burcin Özdirik, Tobias Müller, Alexander Wree, Frank Tacke, Michael Sigal
International Journal of Molecular Sciences.2021; 22(13): 6975.     CrossRef
Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis
Norihisa Nishimura, Kosuke Kaji, Koh Kitagawa, Yasuhiko Sawada, Masanori Furukawa, Takahiro Ozutsumi, Yukihisa Fujinaga, Yuki Tsuji, Hiroaki Takaya, Hideto Kawaratani, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Hiroshi Fukui, Hitoshi Yoshiji
International Journal of Molecular Sciences.2021; 22(13): 6921.     CrossRef
Intestinal Barrier in Human Health and Disease
Natalia Di Tommaso, Antonio Gasbarrini, Francesca Romana Ponziani
International Journal of Environmental Research and Public Health.2021; 18(23): 12836.     CrossRef
Friend or Foe? Impacts of Dietary Xylans, Xylooligosaccharides, and Xylanases on Intestinal Health and Growth Performance of Monogastric Animals
Jonathan T. Baker, Marcos E. Duarte, Debora M. Holanda, Sung Woo Kim
Animals.2021; 11(3): 609.     CrossRef
β-blockers in advanced cirrhosis: More friend than enemy
Ki Tae Yoon, Hongqun Liu, Samuel S. Lee
Clinical and Molecular Hepatology.2021; 27(3): 425.     CrossRef
Eradication of Chronic HCV Infection: Improvement of Dysbiosis Only in Patients Without Liver Cirrhosis
Freya Wellhöner, Nico Döscher, Franziska Woelfl, Marius Vital, Iris Plumeier, Silke Kahl, Andrej Potthoff, Michael Peter Manns, Dietmar Helmut Pieper, Markus Cornberg, Heiner Wedemeyer, Benjamin Heidrich
Hepatology.2021; 74(1): 72.     CrossRef
Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update
Hiroshi Fukui
Gut and Liver.2021; 15(5): 666.     CrossRef
Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma
Watcharin Loilome, Hasaya Dokduang, Manida Suksawat, Sureerat Padthaisong
Expert Opinion on Investigational Drugs.2021; 30(9): 985.     CrossRef
Gut–Liver Axis: Liver Sinusoidal Endothelial Cells Function as the Hepatic Barrier in Colitis-Induced Liver Injury
Yang Wang, Yifan Zhang, Yun Liu, Jun Xu, Yulan Liu
Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
Satya Priya Sharma, Ki Tae Suk, Dong Joon Kim
World Journal of Gastroenterology.2021; 27(37): 6161.     CrossRef
Effect of Additional Clostridium butyricum on the Intestinal Flora of Chronic Hepatitis B Patients Treated with Entecavir
Yu-Xia Lu, Yi-Zhong Chang, Ping Liang, Chang-Qing Yang
Infectious Diseases and Therapy.2021; 10(3): 1519.     CrossRef
PTP1B promotes macrophage activation by regulating the NF-κB pathway in alcoholic liver injury
Lei Yang, Ying-yin Sun, Ya-ru Liu, Na-na Yin, Fang-tian Bu, Hai-xia Yu, Xiao-sa Du, Jun Li, Cheng Huang
Toxicology Letters.2020; 319: 11.     CrossRef
The assembly of integrated rat intestinal‐hepatocyte cultures
Anjaney Kothari, Padmavathy Rajagopalan
Bioengineering & Translational Medicine.2020;[Epub]     CrossRef
Nonpharmacologic Management of Hepatic Encephalopathy
Vanessa Weir, K. Rajender Reddy
Clinics in Liver Disease.2020; 24(2): 243.     CrossRef
The correlation between intestinal mucosal lesions and hepatic dysfunction in patients without chronic liver disease
Li-Hao Wu, Mei-Hui Chen, Jie-Yi Cai, Yu Yuan, Li-Quan Wu, Hui-Min Zhou, Lan Li, Kayiu Wan, Xing-Xiang He
Medicine.2020; 99(7): e18837.     CrossRef
Maternal hepatitis B or hepatitis C virus carrier status and long‐term infectious morbidity of the offspring: A population‐based cohort study
Naim Abu Freha, Tamar Wainstock, Liat Poupko, Avni Yonat Shemer, Ruslan Sergienko, Eyal Sheiner
Journal of Viral Hepatitis.2020; 27(8): 794.     CrossRef
The role of oligosaccharides and polysaccharides of xylan and mannan in gut health of monogastric animals
Utsav P. Tiwari, Stephen A. Fleming, Muhammed S. Abdul Rasheed, R. Jha, Ryan N. Dilger
Journal of Nutritional Science.2020;[Epub]     CrossRef
Nonalcoholic fatty liver disease and portal hypertension
Marvin Ryou, Nicholas Stylopoulos, Gyorgy Baffy
Exploration of Medicine.2020; 1(3): 149.     CrossRef
Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer
Anna Zagórska, Paqui G Través, Lidia Jiménez-García, Jenna D Strickland, Joanne Oh, Francisco J Tapia, Rafael Mayoral, Patrick Burrola, Bryan L Copple, Greg Lemke
Life Science Alliance.2020; 3(8): e202000694.     CrossRef
Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis
Yong-Tao Li, Jian-Rong Huang, Mei-Lian Peng
BioMed Research International.2020; 2020: 1.     CrossRef
The hepatic microenvironment and regulatory T cells
Daniel Osei-Bordom, Amber G. Bozward, Ye Htun Oo
Cellular Immunology.2020; 357: 104195.     CrossRef
Three-tissue microphysiological system for studying inflammatory responses in gut-liver Axis
Joong-won Jeon, Nakwon Choi, Seung Hwan Lee, Jong Hwan Sung
Biomedical Microdevices.2020;[Epub]     CrossRef
Alcohol decreases intestinal ratio of Lactobacillus to Enterobacteriaceae and induces hepatic immune tolerance in a murine model of DSS-colitis
Paulius V. Kuprys, Abigail R. Cannon, Jennifer Shieh, Noama Iftekhar, Sun K. Park, Joshua M. Eberhardt, Xianzhong Ding, Mashkoor A. Choudhry
Gut Microbes.2020; 12(1): 1838236.     CrossRef
Determinación de la microbiota intestinal en pacientes cirróticos de población mestizo-mexicana
C. Pérez-Monter, I. Escalona-Nandez, A. Estanes-Hernández, L.G. Noriega-López, A. Torre-Delgadillo
Revista de Gastroenterología de México.2019; 84(1): 26.     CrossRef
Intestinal microbiota assessment in cirrhotic patients from a Mexican mestizo population
C. Pérez-Monter, I. Escalona-Nandez, A. Estanes-Hernández, L.G. Noriega-López, A. Torre-Delgadillo
Revista de Gastroenterología de México (English Edition).2019; 84(1): 26.     CrossRef
Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
Amandeep K. Dhillon, Martin Kummen, Marius Trøseid, Sissel Åkra, Evaggelia Liaskou, Bjørn Moum, Mette Vesterhus, Tom H. Karlsen, Ingebjørg Seljeflot, Johannes R. Hov, Gabriele Missale
Liver International.2019; 39(2): 371.     CrossRef
Plasma levels of soluble ST2, but not IL-33, correlate with the severity of alcoholic liver disease
Zijian Sun, Binxia Chang, Ang Huang, Shuli Hao, Miaomiao Gao, Ying Sun, Ming Shi, Lei Jin, Wei Zhang, Jun Zhao, Guangju Teng, Lin Han, Hui Tian, Qingsheng Liang, Ji-Yuan Zhang, Zhengsheng Zou
Journal of Cellular and Molecular Medicine.2019; 23(2): 887.     CrossRef
Role of the Gut-Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship
Naoko Ohtani, Norifumi Kawada
Hepatology Communications.2019; 3(4): 456.     CrossRef
Mechanism of neoagarotetraose protects against intense exercise-induced liver injury based on molecular ecological network analysis
Xin Chen, Jiahong Yu, Changhu Xue, Yuming Wang, Qingjuan Tang, Xiangzhao Mao
Bioscience, Biotechnology, and Biochemistry.2019; 83(7): 1227.     CrossRef
Bacillus amyloliquefaciens SC06 Protects Mice Against High-Fat Diet-Induced Obesity and Liver Injury via Regulating Host Metabolism and Gut Microbiota
Yang Wang, Yanping Wu, Baikui Wang, Han Xu, Xiaoqiang Mei, Xiaogang Xu, Xiaoping Zhang, Jiajia Ni, Weifen Li
Frontiers in Microbiology.2019;[Epub]     CrossRef
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
Hiroshi Fukui
Diseases.2019; 7(4): 58.     CrossRef
Non-viral liver diseases: pathogenetic approaches to therapy
M. A. Osadchuk, E. D. Mironova
Medical alphabet.2019; 3(20): 30.     CrossRef
Bowel Wall Thickness, Elasticity, Intestinal Permeability, and Inflammatory Cytokines in Patients with Cirrhosis and Ascites
Sang Hyuk Lee, Heon-Ju Kwon, Nam Hee Kim, Hong Joo Kim, Yong Kyun Cho, Woo Kyu Jeon, Eun Hye Park, Byung Ik Kim
The Korean Journal of Medicine.2019; 94(6): 511.     CrossRef
Role of bile acids in the diagnosis and progression of liver cirrhosis: A prospective observational study
Ning Liu, Jiao Feng, Yang Lv, Qing Liu, Jingfan Deng, Yujing Xia, Chuanyong Guo, Yingqun Zhou
Experimental and Therapeutic Medicine.2019;[Epub]     CrossRef
Gut–liver axis, cirrhosis and portal hypertension: the chicken and the egg
Juan P. Arab, Rosa M. Martin-Mateos, Vijay H. Shah
Hepatology International.2018; 12(S1): 24.     CrossRef
Elevated systemic zonula occludens 1 is positively correlated with inflammation in cirrhosis
Ashwini Karthikeyan, Pazhanivel Mohan, Palanivel Chinnakali, Balasubramaniyan Vairappan
Clinica Chimica Acta.2018; 480: 193.     CrossRef
Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial
Hyung Joon Yim, Sang Jun Suh, Young Kul Jung, Sun Young Yim, Yeon Seok Seo, Yu Rim Lee, Soo Young Park, Jae Young Jang, Young Seok Kim, Hong Soo Kim, Byung Ik Kim, Soon Ho Um
American Journal of Gastroenterology.2018; 113(8): 1167.     CrossRef
Chronic moderate alcohol consumption relieves high-fat high-cholesterol diet-induced liver fibrosis in a rat model
Furong Sun, Zhenjie Zhuang, Dai Zhang, Yushuai Chen, Shu Liu, Nan Gao, Junping Shi, Bingyuan Wang
Clinical and Experimental Pharmacology and Physiology.2018; 45(10): 1046.     CrossRef
IgG Antibodies to GlcNAcβand Asialo-GM2 (GA2) Glycans as Potential Markers of Liver Damage in Chronic Hepatitis C and the Efficacy of Antiviral Treatment
Eugeniy Smorodin, Boris Sergeyev, Oleg Kurtenkov, Tatiana Kuznetsova, Julia Geller
Disease Markers.2018; 2018: 1.     CrossRef
Correlation of liver function with intestinal flora, vitamin deficiency and IL-17A in patients with liver cirrhosis
Haijuan Mou, Fengying Yang, Jianqin Zhou, Cuixia Bao
Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
Alcohol Modulation of the Postburn Hepatic Response
Michael M. Chen, Stewart R. Carter, Brenda J. Curtis, Eileen B. O’Halloran, Richard L. Gamelli, Elizabeth J. Kovacs
Journal of Burn Care & Research.2017; 38(1): e144.     CrossRef
Molecular mechanisms of hepatopulmonary syndrome
I.Ya. Krynytska Krynytska, M.I. Marushchak, I. M. Klishch, I.V. Birchenko
Fiziolohichnyĭ zhurnal.2017; 63(3): 90.     CrossRef
Treatment options for alcoholic and non-alcoholic fatty liver disease: A review
Sukhpreet Singh, Natalia A Osna, Kusum K Kharbanda
World Journal of Gastroenterology.2017; 23(36): 6549.     CrossRef
Dietary capsaicin and antibiotics act synergistically to reduce non-alcoholic fatty liver disease induced by high fat diet in mice
Jingjuan Hu, Haihua Luo, Yong Jiang, Peng Chen
Oncotarget.2017; 8(24): 38161.     CrossRef
Pathogenesis of nonalcoholic steatohepatitis
Wensheng Liu, Robert D. Baker, Tavleen Bhatia, Lixin Zhu, Susan S. Baker
Cellular and Molecular Life Sciences.2016; 73(10): 1969.     CrossRef
Pathogenesis of Alcoholic Liver Disease
Winston Dunn, Vijay H. Shah
Clinics in Liver Disease.2016; 20(3): 445.     CrossRef
Alcohol and lung injury and immunity
Samantha M. Yeligar, Michael M. Chen, Elizabeth J. Kovacs, Joseph H. Sisson, Ellen L. Burnham, Lou Ann S. Brown
Alcohol.2016; 55: 51.     CrossRef
New treatment options for alcoholic hepatitis
Saggere Muralikrishna Shasthry, Shiv Kumar Sarin
World Journal of Gastroenterology.2016; 22(15): 3892.     CrossRef
Inhibition of cyclooxygenase-2 alleviates liver cirrhosis via improvement of the dysfunctional gut-liver axis in rats
Jin-Hang Gao, Shi-Lei Wen, Huan Tong, Chun-Hui Wang, Wen-Juan Yang, Shi-Hang Tang, Zhao-Ping Yan, Yang Tai, Cheng Ye, Rui Liu, Zhi-Yin Huang, Ying-Mei Tang, Jin-Hui Yang, Cheng-Wei Tang
American Journal of Physiology-Gastrointestinal and Liver Physiology.2016; 310(11): G962.     CrossRef
Changes of Intestinal Functions in Liver Cirrhosis
Hiroshi Fukui, Reiner Wiest
Inflammatory Intestinal Diseases.2016; 1(1): 24.     CrossRef
IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats
Tian-Yu Zhao, Li-Ping Su, Chun-Ye Ma, Xiao-Han Zhai, Zhi-Jun Duan, Ying Zhu, Gang Zhao, Chun-Yan Li, Li-Xia Wang, Dong Yang
BMC Gastroenterology.2015;[Epub]     CrossRef
Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis
Sang Hak Han, Ki Tae Suk, Dong Joon Kim, Moon Young Kim, Soon Koo Baik, Young Don Kim, Gab Jin Cheon, Dae Hee Choi, Young Lim Ham, Dong Hoon Shin, Eun Ji Kim
European Journal of Gastroenterology & Hepatology.2015; 27(11): 1300.     CrossRef
Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001)
Mitsuo Shimada, Yuji Morine, Hiroaki Nagano, Etsuro Hatano, Takashi Kaiho, Masaru Miyazaki, Toru Kono, Toshiya Kamiyama, Satoshi Morita, Junichi Sakamoto, Mitsuo Kusano, Shigetoyo Saji, Takashi Kanematsu, Masaki Kitajima
International Journal of Clinical Oncology.2015; 20(1): 95.     CrossRef
The relevance of intestinal dysbiosis in liver transplant candidates
M. Grąt, W. Hołówko, K.M. Wronka, K. Grąt, Z. Lewandowski, I. Kosińska, M. Krasnodębski, M. Wasilewicz, M. Gałęcka, P. Szachta, H. Zborowska, W. Patkowski, M. Krawczyk
Transplant Infectious Disease.2015; 17(2): 174.     CrossRef
Gut Microbiota and Host Reaction in Liver Diseases
Hiroshi Fukui
Microorganisms.2015; 3(4): 759.     CrossRef
Hepatic Hemangioma in Celiac Patients: Data from a Large Consecutive Series
Sara Massironi, Federica Branchi, Roberta Elisa Rossi, Mirella Fraquelli, Luca Elli, Maria Teresa Bardella, Federica Cavalcoli, Dario Conte
Gastroenterology Research and Practice.2015; 2015: 1.     CrossRef
Effects of Lycium barbarum on bacterial translocation in thioacetamide-induced liver injury in rats
Y Bilgic, MMM Harputluoglu, O Kutlu, U Demirel, M Gul, B Otlu, I Temel, S Gursoy, R Dertli, EB Selcuk, I Yilmaz, T Kilis
European Journal of Inflammation.2015; 13(3): 154.     CrossRef
Gut microbiota and liver diseases
Masami Minemura
World Journal of Gastroenterology.2015; 21(6): 1691.     CrossRef
Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis
Melisa Dirchwolf
World Journal of Hepatology.2015; 7(16): 1974.     CrossRef
Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia
Hiroshi Fukui
World Journal of Hepatology.2015; 7(3): 425.     CrossRef
Pathophysiology of Portal Hypertension
Yasuko Iwakiri
Clinics in Liver Disease.2014; 18(2): 281.     CrossRef
Pre-eclampsia renamed and reframed: Intra-abdominal hypertension in pregnancy
Diane J. Sawchuck, Bernd K. Wittmann
Medical Hypotheses.2014; 83(5): 619.     CrossRef
The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver Disease
Silvia Ferolla, Geyza Armiliato, Cláudia Couto, Teresa Ferrari
Nutrients.2014; 6(12): 5583.     CrossRef
Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
William Peverill, Lawrie Powell, Richard Skoien
International Journal of Molecular Sciences.2014; 15(5): 8591.     CrossRef
Effects of Korean Red Ginseng (Panax ginseng), urushiol (Rhus vernicifera Stokes), and probiotics (Lactobacillus rhamnosus R0011 and Lactobacillus acidophilus R0052) on the gut–liver axis of alcoholic liver disease
Chang Seok Bang, So Hyung Hong, Ki Tae Suk, Jin Bong Kim, Sang Hak Han, Hotaik Sung, Eun Ji Kim, Myoung Jo Kim, Moon Young Kim, Soon Koo Baik, Dong Joon Kim
Journal of Ginseng Research.2014; 38(3): 167.     CrossRef
Role of a Bacillus subtilis Direct-Fed Microbial on Digesta Viscosity, Bacterial Translocation, and Bone Mineralization in Turkey Poults Fed with a Rye-Based Diet
Juan D. Latorre, Xochitl Hernandez-Velasco, Michael H. Kogut, Jose L. Vicente, Ross Wolfenden, Amanda Wolfenden, Billy M. Hargis, Vivek A. Kuttappan, Guillermo Tellez
Frontiers in Veterinary Science.2014;[Epub]     CrossRef
n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis
Angela Provenzano, Stefano Milani, Francesco Vizzutti, Wanda Delogu, Nadia Navari, Erica Novo, Marina Maggiora, Valter Maurino, Giacomo Laffi, Maurizio Parola, Fabio Marra
Liver International.2014; 34(6): 918.     CrossRef
Alcoholic liver disease: Treatment
Ki Tae Suk
World Journal of Gastroenterology.2014; 20(36): 12934.     CrossRef
An alteration of the gut-liver axis drives pulmonary inflammation after intoxication and burn injury in mice
Michael M. Chen, Anita Zahs, Mary M. Brown, Luis Ramirez, Jerrold R. Turner, Mashkoor A. Choudhry, Elizabeth J. Kovacs
American Journal of Physiology-Gastrointestinal and Liver Physiology.2014; 307(7): G711.     CrossRef
Toll-Like Receptor 2 Activation by β2→1-Fructans Protects Barrier Function of T84 Human Intestinal Epithelial Cells in a Chain Length–Dependent Manner
Leonie M. Vogt, Diederick Meyer, Gerdie Pullens, Marijke M. Faas, Koen Venema, Uttara Ramasamy, Henk A. Schols, Paul de Vos
The Journal of Nutrition.2014; 144(7): 1002.     CrossRef
Reply to: “Uncovering the molecular events associated with increased intestinal permeability in liver cirrhosis: The pivotal role of enterocyte tight junctions and future perspectives”
Johannie du Plessis, Schalk W. van der Merwe
Journal of Hepatology.2013; 59(5): 1146.     CrossRef
The gut microbiota and the liver: implications for clinical practice
Eamonn M Quigley, Howard P Monsour
Expert Review of Gastroenterology & Hepatology.2013; 7(8): 723.     CrossRef
Targeting the Gut–Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers
Bjørn S. Madsen, Troels Havelund, Aleksander Krag
Advances in Therapy.2013; 30(7): 659.     CrossRef